Diethylpropion Extended Release and Moxetumomab pasudotox-tdfk Intravenous
Determining the interaction of Diethylpropion Extended Release and Moxetumomab pasudotox-tdfk Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: diethylpropion
Brand name: Tenuate, Tenuate Dospan
Synonyms: Diethylpropion
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Diethylpropion Extended Release-Moxifloxacin
- Diethylpropion Extended Release-Moxifloxacin (Systemic)
- Diethylpropion Extended Release-Moxifloxacin Hydrochloride
- Diethylpropion Extended Release-Moxifloxacin Injection
- Diethylpropion Extended Release-Moxifloxacin Intravenous
- Diethylpropion Extended Release-Moxifloxacin Tablets
- Moxetumomab pasudotox-tdfk Intravenous-Diethylpropion Hydrochloride
- Moxetumomab pasudotox-tdfk Intravenous-Diethylpropion Tablets
- Moxetumomab pasudotox-tdfk Intravenous-Difenoxin and Atropine
- Moxetumomab pasudotox-tdfk Intravenous-Differin
- Moxetumomab pasudotox-tdfk Intravenous-Differin (Adapalene)
- Moxetumomab pasudotox-tdfk Intravenous-Differin Cream